Abstract
The cyclin-dependent kinase inhibitor p21Waf1/Cip1 is a downstream effector of the p53-dependent cell growth arrest. We report herein that p21 was cleaved by caspase-3/CPP32 at the site of DHVD112↓L during the DNA damage-induced apoptosis of cancer cells. The cleaved p21 fragment could no more arrest the cells in G1 phase nor suppress the cells undergoing apoptosis because it failed to bind to the proliferating cell nuclear antigen (PCNA) and lost its capability to localize in the nucleus. Thus, caspase-3-mediated cleavage and inactivation of p21 protein may convert cancer cells from growth arrest to undergoing apoptosis, leading to the acceleration of chemotherapy-induced apoptotic process in cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM and Kaelin Jr WG. . 1996 Mol. Cell. Biol. 16: 6623–6633.
Ball KL, Lain S, Fahraeus R, Smythe C and Lane DP. . 1997 Curr. Biol. 7: 71–80.
Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. . 1995 Nature 377: 552–557.
Chen IT, Akamatsu M, Smith ML, Lung FD, Duba D, Roller PP, Fornace Jr AJ and O'Connor PM. . 1996 Oncogene 12: 595–607.
Chen J, Jackson PK, Kirschner MW and Dutta A. . 1995 Nature 374: 386–388.
Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. . 1995 Cell 82: 675–684.
Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. . 1994 Cell 76: 1013–1023.
El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. . 1994 Cancer Res. 54: 1169–1174.
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J. . 1994 Proc. Natl. Acad. Sci. USA 91: 8655–8659.
Fotedar R, Flatt J, Gupta S, Margolis RL, Fitzgerald P, Messier H and Fotedar A. . 1995 Mol. Cell. Biol. 15: 932–942.
Fujita N, Nagahashi A, Nagashima K, Rokudai S and Tsuruo T. . 1998 Oncogene 17: 1295–1304.
Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC and Holbrook NJ. . 1997 Oncogene 14: 929–935.
Gorospe M and Holbrook NJ. . 1996 Cancer Res. 56: 475–479.
Gu Y, Turck CW and Morgan DO. . 1993 Nature 366: 707–710.
Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP and Wei N. . 1995 Mol. Biol. Cell 6: 387–400.
King KL and Cidlowski JA. . 1995 J. Cell. Biochem. 58: 175–180.
Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD. . 1997 Science 275: 1132–1136.
Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP and Salvesen G. . 1994 J. Biol. Chem. 269: 19331–19337.
Lee S-H, Fujita N, Mashima T and Tsuruo T. . 1996 Oncogene 13: 2131–2139.
Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI and Harris CC. . 1991 Cancer Res. 51: 4090–4096.
Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, Roberts JM and Ross R. . 1998 Mol. Cell 1: 553–563.
Li R, Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 371: 534–537.
Luo Y, Hurwitz J and Massague J. . 1995 Nature 375: 159–161.
Martin SJ and Green DR. . 1995 Cell 82: 349–352.
Mashima T, Naito M, Kataoka S, Kawai H and Tsuruo T. . 1995 Biochem. Biophys. Res. Commun. 209: 907–915.
Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW and Tsuruo T. . 1997 Oncogene 14: 1007–1012.
Meikrantz W and Schlegel R. . 1995 J. Cell. Biochem. 58: 160–174.
Meikrantz W and Schlegel R. . 1996 J. Cell. Biochem. 271: 10205–10209.
Miyashita T and Reed JC. . 1995 Cell 80: 293–299.
Morgan DO. . 1995 Nature 374: 131–134.
Nakanishi M, Robetorye RS, Adami GR, Pereira-Smith OM and Smith JR. . 1995a EMBO J. 14: 555–563.
Nakanishi M, Robetorye RS, Pereira-Smith OM and Smith JR. . 1995b J. Biol. Chem. 270: 17060–17063.
Nicholson DW and Thornberry NA. . 1997 Trends Biochem. Sci. 22: 299–307.
Oltvai ZN, Milliman CL and Korsmeyer SJ. . 1993 Cell 74: 609–619.
Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross AH. . 1996 Mol. Cell. Biol. 16: 1335–1341.
Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B. . 1996 Genes Dev. 10: 1945–1952.
Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B. . 1997 Nature 389: 300–305.
Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Borner C. . 1998 Nature 391: 496–499.
Shi L, Nishioka WK, Th'ng J, Bradbury EM, Litchfield DW and Greenberg AH. . 1994 Science 263: 1143–1145.
Shimizu T, O'Connor PM, Kohn KW and Pommier Y. . 1995 Cancer Res. 55: 228–231.
Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD and Wong WW. . 1997 J. Biol. Chem. 272: 9677–9682.
Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT and Nicholson DW. . 1997 J. Biol. Chem. 272: 17907–17911.
Tomida A, Suzuki H, Kim H-D and Tsuruo T. . 1996 Oncogene 13: 2699–2705.
Villa P, Kaufmann SH and Earnshaw WC. . 1997 Trends Biochem. Sci. 22: 388–393.
Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 369: 574–578.
Waldman T, Kinzler KW and Vogelstein B. . 1995 Cancer Res. 55: 5187–5190.
Wang J and Walsh K. . 1996 Science 273: 359–361.
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. . 1993 Nature 366: 701–704.
Xue D and Horvitz HR. . 1995 Nature 377: 248–251.
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X. . 1997 Science 275: 1129–1132.
Acknowledgements
This study was supported in part by a special grant for Advanced Research on Cancer, a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture of Japan, a grant from the Vehicle Racing Commemorative Foundation, and a grant from the Organization for Pharmaceutical Safety and Research (OPSR), Japan. During the review of this manuscript, Gervais et al. also reported that the p21 was cleaved by caspases during apoptosis induced by γ-irradiation (J Biol Chem, 273, 19207 – 19212, 1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, Y., Fujita, N. & Tsuruo, T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 18, 1131–1138 (1999). https://doi.org/10.1038/sj.onc.1202426
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202426
Keywords
This article is cited by
-
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Cellular and Molecular Life Sciences (2023)
-
Formal verification confirms the role of p53 protein in cell fate decision mechanism
Theory in Biosciences (2023)
-
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation
Cellular Oncology (2021)
-
Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells
Apoptosis (2019)
-
P21Waf1/Cip1 depletion promotes dexamethasone-induced apoptosis in osteoblastic MC3T3-E1 cells by inhibiting the Nrf2/HO-1 pathway
Archives of Toxicology (2018)